関連ニュース

Santhera Pharmaceuticals Holding AG (SPHDF) Q2 2026 Earnings Call Transcript

Santhera Pharmaceuticals (SIX:SANN, OTC:SPHDF, FRA:S3F0), the Swiss rare-disease drugmaker, is closing in on a financial turning point, according to research house Edison. In a QuickView note publishe